It's far more likely that they 1) saved billions of dollars by not including anti-inflammatory compounds

From the article (emphasis mine):

Novavax is still well-positioned to be the preferred vaccine in developing countries, as its vaccine is less expensive than its competitors and much easier to store than its mRNA rivals.